Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs IONS✓SelectedUSD · IONSGSK vs IONS performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs IONS

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+103.1%
IONS return
-40.1%
Excess return
+143.2%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioIONSExcessAlpha
1D-2.3%-3.7%+1.4%-1.9%
7D-3.0%-4.4%+1.3%-2.6%
30D+0.4%-37.2%+37.6%+4.7%
3M-1.2%-54.0%+52.8%+6.4%
6M+0.9%-63.7%+64.6%+10.8%
YTD+4.0%-65.9%+69.9%+14.8%
1Y+7.3%-63.2%+70.5%+17.5%
3Y+57.1%-44.9%+102.0%+61.5%
5Y+43.0%-17.0%+59.9%+38.2%
10Y+103.1%-41.9%+145.0%+98.3%
All+103.1%-40.1%+143.2%+98.3%

Cumulative growth

Daily Returns

Daily percentage return beside IONS.

Daily Out/Under-Performance

Portfolio return minus IONS return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × IONS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded IONS wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling